Pfizer says it has received initial data showing that a third dose of its existing vaccine is safe & can raise neutralising antibody levels by 5 to 10 fold compared with original vaccine.
Pfizer CEO Dr Albert Bourla also said that the local manufacturing of vaccines by the Serum Institute of India will provide the backbone of vaccinating the Indian people.
Study finds Pfizer-BioNTech vaccine has favourable safety profile in 12-15-year-olds, produces greater immune response than in young adults, is highly effective against Covid-19.
Modi government has so far stood firm on not offering indemnity to Covid vaccine makers. But vaccine shortage could force it reconsider as it negotiates with foreign companies.
Most of the cases occurred in young men, especially those aged 16-19. In most cases, patients were hospitalised for 4 days or less & 95% of the cases were classified as mild.
Pfizer says it is encouraged by both the real-world data and laboratory studies of the vaccine & sees no evidence that 'virus or circulating variants of concern regularly escape protection'.
NITI Aayog member Paul said Centre has engaged continuously with all the major international Covid vaccine makers since mid-2020, including discussions with Pfizer, J&J & Moderna.
Disenfranchisement by institutional fiat is profoundly undemocratic. The effect of the ECI's new documentary process in Bihar will tilt the scales in favour of the BJP.
Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.
India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.
Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.
COMMENTS